IL-10 Levels and Remote Ischemic Preconditioning in Acute Myocardial Infarction

Stopped early · Not applicable

Conditions studied: Acute Myocardial Infarction

In brief

Remote ischemic preconditioning has proven beneficial in patients undergoing percutaneous coronary intervention and coronary artery bypass surgery. Animal studies suggest remote ischemic preconditioning increases levels of interleukin 10. The investigators aim to determine whether remote ischemic preconditioning results in an increase in IL-10 levels in patients following acute myocardial infarction.

Key facts

Study ID

NCT01532206

Run by

Johns Hopkins University

People needed

1

Starts

2013-03-01

Expected to finish

2014-05-01

Last updated by the study team

2016-03-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Acute myocardial infarction

You may not qualify if…

• Cardiogenic shock Active ischemia

Where it is running

• Johns Hopkins Hospital — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.